Lopez-Yurda Marta - Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute

基本信息

浏览量：39

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 67 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Gastric and Duodenal Cancer in Individuals with Lynch Syndrome: a Nationwide Cohort Study

Irene A. Caspers,Ellis L. Eikenboom,Marta Lopez-Yurda,Nicole C. T. van Grieken,Tanya M. Bisseling,Evelien Dekker,Barbara A. J. Bastiaansen,Annemieke Cats,Monique E. van Leerdam

ECLINICALMEDICINE (2024)

引用0浏览0WOS引用

LBA11 Neoadjuvant Nivolumab/relatlimab or Nivolumab/ipilimumab in Triple Negative Breast Cancer with High Tumor-Infiltrating Lymphocytes (Tils)

I. Nederlof, A.L. Rolfes, R.C.A.M. Gielen,G. Awada, M.V. Dongen,H.M. Horlings,K. Van De Vijver,C.A. Drukker,F. van Duijnhoven,M. Lopez-Yurda,I. Mandjes,R.M. Mann,C.E. Loo, C.U. Blank,T.N. Schumacher,R.F. Salgado, M. Kok

Annals of Oncology (2024)

引用0浏览0引用

770P Neoadjuvant Pembrolizumab in Stage IV Ovarian Cancer: the Phase II Neo-Pembro Trial

L. Aronson,B. Thijssen,M. Lopez-Yurda,S. Koole, P. van der Leest,A. León-Castillo,R. Harkes, I. Seignette, J. Sanders, M. Alkemade,I. Kemper, M. Holtkamp,I. Mandjes,A. Broeks, M. Lahaye, M. Rijlaarsdam,D. Van Den Broek,H.M. Horlings, W. van Driel, G.S. Sonke

Annals of Oncology (2024)

引用0浏览0引用

The Predictive Value of FDG PET/CT for Determining Progression-Free Survival in Advanced Stage III-IV BRAF-Mutated Melanoma Patients Treated with Targeted Therapy-What Can Be Learned from Progression

Bernies van der Hiel,Else A. Aalbersberg,Alfons J. M. van den Eertwegh,Linda J. de Wit-van der Veen,Marcel P. M. Stokkel,Marta Lopez-Yurda,Ronald Boellaard,Ellen W. Kapiteijn,Geke A. P. Hospers,Maureen J. B. Aarts,Filip Y. F. L. de Vos,Marye J. Boers-Sonderen,Astrid A. M. van der Veldt,Jan Willem B. de Groot,John B. A. G. Haanen

CLINICAL NUCLEAR MEDICINE（2024）

引用0浏览0WOS引用

596P Dose-individualisation of Fluoropyrimidines in DPYD Wild-Type Patients: Final Results from the Alpe2U Study

N. Heersche,J.E. Knikman,M. De With,M. Lopez-Yurda,A. Baars,G-J. Creemers, H. Droogendijk,E. Fiets,M. Deenen, R. Van Schaik, B. van den Bosch, E. Oomen-de Hoop, H. Rosing,J. Swen, H. Gelderblom, J.H.M. Schellens, J.H. Beijnen,R.H. Mathijssen,H-J. Guchelaar, A. Cats

Annals of Oncology (2024)

引用0浏览0引用

Tumour Microenvironment Characterisation to Stratify Patients for Hyperthermic Intraperitoneal Chemotherapy in High-Grade Serous Ovarian Cancer (OVHIPEC-1)

BRITISH JOURNAL OF CANCERno. 3 (2024): 565-576

引用0浏览0WOSNATURE引用

Squamous Cell Carcinoma Antigen in the Follow-up of Patients with Head and Neck Cancer

Emma J. A. Schepens,Abrahim Al-Mamgani,Luc H. E. Karssemakers,Daan van den Broek,Michiel. W. M. van den Brekel,Marta Lopez-Yurda

OTOLARYNGOLOGY-HEAD AND NECK SURGERYno. 2 (2024): 422-430

引用0浏览0WOS引用

1090P High Concurrent Interferon Gamma Signature Expression in the Primary Tumor and Lymph Node Metastasis is Associated with Superior Outcome Upon Neoadjuvant Ipilimumab + Nivolumab in Stage III Melanoma

L. Hoeijmakers,P. Dimitriadis,S. Cornelissen, I. Reijers,B. van de Wiel, R.A. Scolyer,R.P.M. Saw, A.J. Spillane,A. Broeks,M. Lopez-Yurda,L. Grijpink-Ongering, G. Hospers, A.M. Menzies,A.C.J. van Akkooi,W. Van Houdt, G.V. Long, C.U. Blank

Annals of Oncology (2024)

引用0浏览0引用

Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Early-Stage Triple-Negative Breast Cancer: a Phase 2 Adaptive Trial

Iris Nederlof,Olga I Isaeva, Manon de Graaf, Robbert C A M Gielen,Noor A M Bakker, Adrianne L Rolfes,Hannah Garner,Bram Boeckx,Joleen J H Traets,Ingrid A M Mandjes,Michiel de Maaker,Thomas van Brussel,Maksim Chelushkin,Elisa Champanhet,Marta Lopez-Yurda,Koen van de Vijver,José G van den Berg,Ingrid Hofland, Natasja Klioueva,Ritse M Mann,Claudette E Loo,Frederieke H van Duijnhoven, Victoria Skinner, Sylvia Luykx,Emile Kerver,Ekaterina Kalashnikova,Marloes G J van Dongen,Gabe S Sonke,Sabine C Linn,Christian U Blank,Karin E de Visser, Roberto Salgado,Lodewyk F A Wessels,Caroline A Drukker,Ton N Schumacher,Hugo M Horlings,Diether Lambrechts,Marleen Kok

Nature medicineno. 11 (2024): 3223-3235

引用0浏览0WOSNATURE引用

LBA42 Distant Metastasis-Free Survival of Neoadjuvant Nivolumab Plus Ipilimumab Versus Adjuvant Nivolumab in Resectable, Macroscopic Stage III Melanoma: the NADINA Trial

M.W. Lucas, A.M. Menzies,M. Lopez-Yurda, R.A. Scolyer,B. van de Wiel,R.P.M. Saw,W. Van Houdt, N. Maher,A. Torres Acosta,M. Boers-Sonderen, G. Hospers,M.S. Carlino,J.W. de Groot, E. Kapiteijn,K. Suijkerbuijk, P. Rutkowski, S.K. Sandhu,A.A.M. Van der Veldt, G.V. Long, C.U. Blank

Annals of Oncology (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn